243 related articles for article (PubMed ID: 16081512)
41. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
42. c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum.
Senhaji MA; Abidi O; Nadifi S; Benchikhi H; Khadir K; Ben Rekaya M; Eloualid A; Messaoud O; Abdelhak S; Barakat A
Arch Dermatol Res; 2013 Jan; 305(1):53-57. PubMed ID: 23143338
[TBL] [Abstract][Full Text] [Related]
43. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
44. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
45. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum.
Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
J Invest Dermatol; 1997 Sep; 109(3):306-9. PubMed ID: 9284095
[TBL] [Abstract][Full Text] [Related]
46. Efficient repair of cyclobutane pyrimidine dimers at mutational hot spots is restored in complemented Xeroderma pigmentosum group C and trichothiodystrophy/xeroderma pigmentosum group D cells.
Zhou NY; Bates SE; Bouziane M; Stary A; Sarasin A; O'Connor TR
J Mol Biol; 2003 Sep; 332(2):337-51. PubMed ID: 12948486
[TBL] [Abstract][Full Text] [Related]
47. Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs.
Fu L; Xu X; Ren R; Wu J; Zhang W; Yang J; Ren X; Wang S; Zhao Y; Sun L; Yu Y; Wang Z; Yang Z; Yuan Y; Qiao J; Izpisua Belmonte JC; Qu J; Liu GH
Protein Cell; 2016 Mar; 7(3):210-21. PubMed ID: 26874523
[TBL] [Abstract][Full Text] [Related]
48. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function.
Khan SG; Muniz-Medina V; Shahlavi T; Baker CC; Inui H; Ueda T; Emmert S; Schneider TD; Kraemer KH
Nucleic Acids Res; 2002 Aug; 30(16):3624-31. PubMed ID: 12177305
[TBL] [Abstract][Full Text] [Related]
49. Repair of damaged DNA by extracts from a xeroderma pigmentosum complementation group A revertant and expression of a protein absent in its parental cell line.
Jones CJ; Cleaver JE; Wood RD
Nucleic Acids Res; 1992 Mar; 20(5):991-5. PubMed ID: 1549511
[TBL] [Abstract][Full Text] [Related]
50. A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C.
Macke EL; Morales-Rosado JA; Gupta A; Schmitz CT; Kruisselbrink T; Lanpher B; Klee EW
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843428
[TBL] [Abstract][Full Text] [Related]
51. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
52. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
53. Loss of Function Variants in the XPC Causes Severe Xeroderma Pigmentosum in Three Large Consanguineous Families.
Nawal W; Ullah A; Ullah U; Farrakh K; Ahmad F; Khan H; Ahmad GS; Khan B; Ansar M; Kalsoom UE; Ahmad W
Klin Padiatr; 2022 May; 234(3):123-129. PubMed ID: 34544175
[TBL] [Abstract][Full Text] [Related]
54. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
[TBL] [Abstract][Full Text] [Related]
55. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
56. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
57. High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis.
Ben Rekaya M; Messaoud O; Talmoudi F; Nouira S; Ouragini H; Amouri A; Boussen H; Boubaker S; Mokni M; Mokthar I; Abdelhak S; Zghal M
J Hum Genet; 2009 Jul; 54(7):426-9. PubMed ID: 19478817
[TBL] [Abstract][Full Text] [Related]
58. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC.
Sands AT; Abuin A; Sanchez A; Conti CJ; Bradley A
Nature; 1995 Sep; 377(6545):162-5. PubMed ID: 7675084
[TBL] [Abstract][Full Text] [Related]
59. DNA-based diagnosis of xeroderma pigmentosum group C by Whole-genome scan using single-nucleotide polymorphism microarray.
Lam CW; Cheung KK; Luk NM; Chan SW; Lo KK; Tong SF
J Invest Dermatol; 2005 Jan; 124(1):87-91. PubMed ID: 15654957
[TBL] [Abstract][Full Text] [Related]
60. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]